Investigational Site Number 1026

New York, New York 10029

0 studies enrolling now · 1 studies all time

What they study most

Relapsing Remitting Multiple Sclerosis

Studies at this site

• Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409 — Completed